Analyst Ratings for Mednax (MD)
MD Rating Summary
MD Price Target Summary
- Highest: $108.00 (Jefferies)
- Lowest: $76.00 (Deutsche Bank)
- Average: $86.50
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$86.50 (-6.3%)
Avg. $ Target:
$86.50 (-6.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/4/2013 | Goldman Sachs | New Coverage | Neutral (N/A) |
96.00 (N/A) |
86.53 | 92.27 | 6.63% | Details |
| 11/2/2012 | Stephens | Downgrade | Equal Weight (Overweight) |
78.00 (85.00) |
73.41 | 92.27 | 25.69% | Details |
| 11/2/2012 | Deutsche Bank | Upgrade | Hold (Sell) |
76.00 (65.00) |
73.41 | 92.27 | 25.69% | Details |
| 6/5/2012 | Stifel Nicolaus » Updated 9/20/2012 |
New Coverage | Buy (N/A) |
83.00 (74.00) |
60.20 | 92.27 | 53.27% | Details |
| 12/22/2011 | BB&T Capital | New Coverage | Buy (N/A) |
80.00 (N/A) |
68.53 | 92.27 | 34.64% | Details |
| 10/5/2011 | Credit Suisse | New Coverage | Neutral (N/A) |
N/A (N/A) |
62.61 | 92.27 | 47.37% | Details |
| 7/27/2011 | Morgan Keegan | Upgrade | Outperform (N/A) |
85.00 (N/A) |
70.50 | 92.27 | 30.88% | Details |
| 6/23/2011 | Piper Jaffray | New Coverage | Overweight (N/A) |
N/A (N/A) |
72.02 | 92.27 | 28.12% | Details |
| 5/4/2011 | Feltl & Co » Updated 9/20/2012 |
Downgrade | Buy (N/A) |
86.00 (79.00) |
72.48 | 92.27 | 27.3% | Details |
| 3/25/2011 | BofA/Merrill Lynch | Upgrade | Buy (N/A) |
N/A (N/A) |
63.78 | 92.27 | 44.67% | Details |
| 2/18/2011 | Collins Stewart | New Coverage | Buy (N/A) |
N/A (N/A) |
64.95 | 92.27 | 42.06% | Details |
| 1/6/2011 | Guggenheim | Upgrade | Neutral (N/A) |
N/A (N/A) |
69.57 | 92.27 | 32.63% | Details |
| 12/20/2010 | RBC Capital | New Coverage | Top Pick (N/A) |
N/A (N/A) |
67.19 | 92.27 | 37.33% | Details |
